Upcoming Events
Past Events
Redeye Fight Cancer Event 2024 (Live broadcast)
BIO-Europe 2023
Jefferies London Healthcare Conference
Nov 14 to Nov 16, 2023
London, UK
Attending: Øystein Rekdal (CEO) and Gjest Breistein (CFO)
LSX: Inv€$tival Showcase
Nov 13, 2023
London, UK
Attending: Øystein Rekdal (CEO) and Gjest Breistein (CFO), with oral presentation
SITC 2023
Nov 1 to Nov 5, 2023
San Diego, USA
Attending: Stephen Worsley (CBO) and Baldur Sveinbjørnsson (CSO)
Optimum: 15th Annual Healthcare Investor Conference
Oct 11, 2023
London, UK
Attending: Øystein Rekdal (CEO), Gjest Breistein (CFO) and Ole Peter Nordby (Head of IR & Communication Manager)
ABGSC Cancer Vaccine Seminar
Aug 28, 2023
ABGSC Oslo office or virtually via dial-in (For more info: Contact ABGSC)
Attending: Øystein Rekdal (CEO)
Arendalsuka
Aug 15, 2023
Arendal
Attending: Øystein Rekdal (CEO), as participant in a conversation
BIO International Convention
ASCO 2023
Jun 2 to Jun 6, 2023
Chicago, IL, USA
Attending: Karsten Bruins Slot, Director Clinical Development
ABGSC Life Science Summit 2023
May 30 to May 31, 2023
Attending: Øystein Rekdal (CEO)
LSX World Congress
May 3 to May 4, 2023
London, UK
Attending: Ole Peter Nordby, Head of IR & Communication Manager and Gjest Breistein, CFO
NYAS Frontiers in Cancer Immunotherapy 2023
May 2 to May 4, 2023
New York, NY and Virtually
Attending: Øystein Rekdal (CEO) and Stephen Worsley (CBO)
Anglonordic Life Science Conference
Immuno UK: In-Person
Mar 28 to Mar 29, 2023
London, UK
Attending: Øystein Rekdal, CEO, with oral presentation
BIO-EUROPE spring
7th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference
Mar 9 to Mar 10, 2023
ILEC Conference Centre & Ibis London Earls Court, London
Attending: Øystein Rekdal, CEO, with oral presentation
Redeye Fight Cancer Seminar – Outlook 2022
Jan 19, 2023
Attending: Øystein Rekdal (CEO), Ole Peter Nordby (Head of IR & Communication Manager) and Gjest Breistein (CFO)
JPM 2023, 41st Annual Healthcare Meeting
Jan 9 to Jan 12, 2023
San Fransisco
Attending: Øystein Rekdal (CEO) and Stephen Worsley (CBO)
ABG Sundal Collier, Oncology Seminar
Capital Markets Day_Lytix
SITC (Society for Immunotherapy of Cancer) 2022
Nov 8 to Nov 12, 2022
Boston
Attending: Øystein Rekdal (CEO), Stephen Worsley (CBO) and Baldur Sveinbjørnsson (CSO)
CICON22 (CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference)
Sep 28 to Oct 1, 2022
New York Hilton Midtown, New York City
Attending: Øystein Rekdal, CEO
NLSDays (Nordic Life Science Days) 2022
Sep 28 to Sep 29, 2022
Malmö, Sweden
Attending: Gjest Breistein, CFO, with oral presentation
5th Annual Next-Gen Immuno-Oncology Conference
Jun 23 to Jun 24, 2022
Boston, USA
Attending: Øystein Rekdal, CEO, with oral presentation
American Society of Clinical Oncology (ASCO) Annual Meeting
Capital Markets Day_Lytix
LSX World Congress
May 10 to May 11, 2022
London
Attending: Ole Peter Nordby, Head of IR & Communication Manager, and Gjest Breistein, CFO, with oral presentation
The Anglonordic Life Science Conference
May 4 to May 5, 2022
London
Attending: Ole Peter Nordby, Head of IR & Communication Manager, with oral presentation
Arctic Securities Biotech
Apr 26, 2022
Webinar
Attending: Øystein Rekdal, CEO, with oral presentation
ACCESS CHINA Biotech Forum
Apr 18 to Apr 19, 2022
Online
Attending: Øystein Rekdal, CEO, with oral presentation
DKBIO2022
Apr 6 to Apr 7, 2022
Boston
Attending: Ole Peter Nordby, Head of IR & Communication Manager, with oral presentation
6th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress
Investordagene 2021 (Finansavisen)
Access China Biotech Forum
ESMO Targeted anticancer therapies virtual congress 2021
Mar 1, 2021
Attending: Øystein Rekdal, with oral presentation and in a live Q&A panel
(Only in Norwegian) Fremtidens kreftbehandling – kreft og kliniske studier
May 27, 2020
Webinar
Attending: Baldur Sveinbjørnsson, CSO, participates in panel debate
ESMO Targeted Anticancer Therapies Congress 2020
Mar 2 to Mar 4, 2020
Paris, France
Attending: Øystein Rekdal, with oral presentation
The third annual Lyfebulb-Helsinn Innovation Summit
38th Annual J.P. Morgan Healthcare Conference
ESMO Immuno-Oncology Congress 2019
Dec 11 to Dec 14, 2019
Geneva Switzerland
Attending: Øystein Rekdal, with oral presentation
Good Morning Meeting on “Biomarkers analysis challenges in Clinical Trials”
Meeting with our Scientific Advisory Board
Feb 21, 2019
Paris
2019 J.P. Morgan Health Care Investor Conference
Nordic-American Life Science (NALS) Conference, Private Company Track
Presentation at Biotech and Money Inv€$tival Showcase
Presentation at Redeye Life Science Seminar
Nov 24, 2017
Haymarket (Hötorget), Stockholm, Sweden
Attending: Håkan Wickholm and Torbjørn Furuseth
Posters at SITC 2017
Nov 8 to Nov 12, 2017
Washington DC
Attending: Andrew Saunders, Øystein Rekdal, Baldur Sveinbjørnsson, Håkan Wickholm & Vibeke Sundvold Gjerstad
Presentation at RedEye Cancer Immunotherapy "Special Event"
Sep 21, 2017
Redeye, Mäster Samuelsgatan 42, 10 tr, Stockholm, Sweden
Attending: Håkan Wickholm and Torbjørn Furuseth
Presentation at Immuno-Oncology Frontiers
Presentation at Nordic Life Science Days
Sep 12 to Sep 14, 2017
Malmö, Sweden
Attending: Håkan Wickholm and Torbjørn Furuseth
ESMO 2017 Congress, Integrating science into oncology for a better patient outcome
Sep 8 to Sep 12, 2017
Madrid, Spain
Attending: Andrew Saunders and Berit Nicolaisen
Presentation at Pareto Securities' 8th Annual Healthcare Conference
Sep 7, 2017
Conference 7A Strandvägen 7A Stockholm, Sweden
Attending: Håkan Wickholm and Torbjørn Furuseth
Posters at Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
Sep 6 to Sep 9, 2017
Mainz/Frankfurt, Germany
Attending: Øystein Rekdal and Baldur Sveinbjørnsson
Biotech Outsourcing Strategies CMC 2017